These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, Tamaki N, Iwaisako K, Kitamura K, Ikai I, Uemoto S. Int J Oncol; 2009 May; 34(5):1303-12. PubMed ID: 19360342 [Abstract] [Full Text] [Related]
6. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer. Izuishi K, Yamamoto Y, Mori H, Kameyama R, Fujihara S, Masaki T, Suzuki Y. Oncol Rep; 2014 Feb; 31(2):701-6. PubMed ID: 24297035 [Abstract] [Full Text] [Related]
7. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Wolfort RM, Papillion PW, Turnage RH, Lillien DL, Ramaswamy MR, Zibari GB. Int Surg; 2010 Feb; 95(1):67-75. PubMed ID: 20480845 [Abstract] [Full Text] [Related]
8. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S. Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736 [Abstract] [Full Text] [Related]
10. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Wudel LJ, Delbeke D, Morris D, Rice M, Washington MK, Shyr Y, Pinson CW, Chapman WC. Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351 [Abstract] [Full Text] [Related]
14. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies. Baek S, Mueller A, Lim YS, Lee HC, Lee YJ, Gong G, Kim JS, Ryu JS, Oh SJ, Lee SJ, Bacher-Stier C, Fels L, Koglin N, Schatz CA, Dinkelborg LM, Moon DH. J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273 [Abstract] [Full Text] [Related]
15. PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline. Salem N, Kuang Y, Wang F, Maclennan GT, Lee Z. Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):144-56. PubMed ID: 19039303 [Abstract] [Full Text] [Related]
16. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. Fukunaga T, Okazumi S, Koide Y, Isono K, Imazeki K. J Nucl Med; 1998 Jun; 39(6):1002-7. PubMed ID: 9627333 [Abstract] [Full Text] [Related]
17. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy. Kim JW, Seong J, Yun M, Lee IJ, Yoon HI, Cho HJ, Han KH. Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1172-8. PubMed ID: 21570203 [Abstract] [Full Text] [Related]
18. Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma. Kuang Y, Schomisch SJ, Chandramouli V, Lee Z. Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jun 01; 143(2):225-31. PubMed ID: 16581304 [Abstract] [Full Text] [Related]
19. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. Yamamoto Y, Nishiyama Y, Kameyama R, Okano K, Kashiwagi H, Deguchi A, Kaji M, Ohkawa M. J Nucl Med; 2008 Aug 01; 49(8):1245-8. PubMed ID: 18632827 [Abstract] [Full Text] [Related]
20. Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using (15)O and (18)F-deoxyglucose. Fukuda K, Taniguchi H, Koh T, Kunishima S, Yamagishi H. Nucl Med Commun; 2004 Jun 01; 25(6):577-83. PubMed ID: 15167517 [Abstract] [Full Text] [Related] Page: [Next] [New Search]